KMI vs RYTM · P/E 24, $62.53B cap vs rev $130.1M
Kinder Morgan Inc (KMI) versus Rhythm Pharmaceuticals Inc (RYTM) — a side-by-side from cached financials, not a winner call.
Kinder Morgan Inc (KMI) is a oil & gas midstream company listed on US.
Rhythm Pharmaceuticals Inc (RYTM) is a biotechnology company listed on NASDAQ.
KMI does not have a complete income-statement cache yet.
Latest reported RYTM revenue for 2024-12-31 was $130.1M. Net income was -$260.6M. Revenue was up 68.1% from 2023-12-31 to 2024-12-31. RYTM currently screens at market cap $6.49B.
KMI currently screens at market cap $62.53B and trailing P/E 24.2. RYTM currently screens at market cap $6.49B.
Not investment advice. Open the KMI and RYTM stock pages for the full models.
Not investment advice.